Submit Content
Get the latest delivered to your inbox
Privacy Policy

Merck & Co., Inc.

Today’s Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions.

We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

    Merck Scientists Launch Research Award to Support Rising Chemists of Color Image

    POSTED 

    01-19-22

    Merck Scientists Launch Research Award to Support Rising Chemists of Color

    The new Merck Research Award for Underrepresented Chemists of Color adds to our company’s efforts to promote diversity, inclusion and equity in all that we do.
    Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine Image

    POSTED 

    01-18-22

    Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

    Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced the signing of a long-term supply agreement with the United Nations Children’s Fund (UNICEF) to facilitate broad global access for molnupiravir, an investigational oral antiviral COVID...
    A Nobel Prize for a Longtime Merck Collaborator Image

    POSTED 

    01-15-22

    A Nobel Prize for a Longtime Merck Collaborator

    Princeton University’s David W.C. MacMillan has been awarded the 2021 Nobel Prize in chemistry, alongside co-winner Benjamin List.
    Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities Image

    POSTED 

    01-10-22

    Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities

    Merck, known as MSD outside the United States and Canada, announced an additional $150 million commitment through Merck for Mothers to further advance the initiative’s mission of helping create a world where no woman has to die giving life.
    How Merck Is Prioritizing Supply Image

    POSTED 

    01-07-22

    How Merck Is Prioritizing Supply

    From the earliest stages of the COVID-19 pandemic, we knew we had a responsibility to mobilize and innovate to rise to the challenge of this unique moment.
    Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort Image

    POSTED 

    01-05-22

    Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort

    Taking on COVID-19 isn’t just a team effort — it’s also a global one. Here at Merck, we’re grateful to all the people who have worked hard to keep us safe, along with everyone around the world helping to combat the pandemic.
    Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 Image

    POSTED 

    12-28-21

    Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19

    Merck and Ridgeback Biotherapeutics announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).
    When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need Image

    POSTED 

    12-20-21

    When the COVID-19 Pandemic Hit, Our Cafeterias Stepped up To Serve People in Need

    A meal distribution program that started at the beginning of the pandemic continues to deliver thousands of meals a week to underserved communities
    Merck Issues $1 Billion Inaugural Sustainability Bond Image

    POSTED 

    12-13-21

    Merck Issues $1 Billion Inaugural Sustainability Bond

    Merck, known as MSD outside the United States and Canada, today announced its inaugural issuance of a $1 billion sustainability bond, which was part of an $8 billion underwritten public offering of notes that closed on Dec. 10, 2021.
    Accelerating Global Access Image

    POSTED 

    12-13-21

    Accelerating Global Access

    Our company is collaborating with a range of partners to enable access for patients around the world
    Merck & Co., Inc. Logo

    Merck & Co., Inc.

    Merck & Co., Inc.

    Join today and get the latest delivered to your inbox